Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/III safety and immunogenicity trial of group A and C meningococcal polysaccharide conjugate vaccine
CTR20192131Phase 3Active
- Sponsor
- Liaoning Chengda Biotechnology Co., Ltd.
- Start
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of meningococcal group A and C conjugate vaccine in meningococcal meningitis, sponsored by Liaoning Chengda Biotechnology Co., Ltd.. Started Nov 2019; status: active.
02
Drugs
meningococcal group A and C conjugate vaccine
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on CTR20192131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192131.